What's Hot

View all perspectives
      Potential Impact of Weight Loss Drugs in Rheumatic Diseases

      Dr. Arthur Kavanaugh highlights a session regarding weight

      Dr. John Cush RheumNow

      1 month ago
      Potential Impact of Weight Loss Drugs in Rheumatic Diseases Dr. Arthur Kavanaugh highlights a session regarding weight loss and improvement in disease outcomes, specific weight loss drugs (SGL-2 and GLP-1), along with downsides when patients stop these medications. Reporting… https://t.co/Ilu2FXK2xi https://t.co/7CKSnfuey4
      Yang et al. Cranial vessel wall MRI in GCA. Quantitated with PEG score. PEG score ocular GCA>non-ocular GCA>non-GC

      Richard Conway RichardPAConway

      1 month ago
      Yang et al. Cranial vessel wall MRI in GCA. Quantitated with PEG score. PEG score ocular GCA>non-ocular GCA>non-GCA. Decreases with treatment. @RheumNow #ACR24 Abstr#2650 https://t.co/e26urOpb7V https://t.co/eekQbzmKYm
      A#2651
      Vasculitis w VEXAS
      81 men, median age 67 - 27% had evid of vasculitis, variable size vessel

      22% SVV- 17/18 cutan

      Eric Dein ericdeinmd

      1 month ago
      A#2651 Vasculitis w VEXAS 81 men, median age 67 - 27% had evid of vasculitis, variable size vessel 22% SVV- 17/18 cutaneous, one peritubular capillaritis on renal bx 2.5% MVV (2 cutan), LVV (2 carotid thickening, 1 had +TA bx), ANCA+ @RheumNow #ACR24 https://t.co/puablIBLCP
      What factors are assoc with uptake of newer meds in RA?

      ➡️Incr use of b/tsDMARDs over 10yrs
      ➡️Use of newer drug

      Mrinalini Dey DrMiniDey

      1 month ago
      What factors are assoc with uptake of newer meds in RA? ➡️Incr use of b/tsDMARDs over 10yrs ➡️Use of newer drugs lower in older ppl, socioeconomic deprived & Asian/Black ppl Could this indicate disparities in access to meds? How can we best address this? Ab2608 #ACR24 @RheumNow
      Subsets of lupus arthritis. Kenneth Kalunian @RheumNow #ACR24 https://t.co/ZmHui126zr

      Antoni Chan MD (Prof) synovialjoints

      1 month ago
      Subsets of lupus arthritis. Kenneth Kalunian @RheumNow #ACR24 https://t.co/ZmHui126zr
      Sullivan et al. Vasculitis in VEXAS. 81 patients. 27% vasculitis. Cutaneous SVV 20%, AAV 2.5%, cutaneous MVV 2.5%, LVV 2

      Richard Conway RichardPAConway

      1 month ago
      Sullivan et al. Vasculitis in VEXAS. 81 patients. 27% vasculitis. Cutaneous SVV 20%, AAV 2.5%, cutaneous MVV 2.5%, LVV 2.5%. @RheumNow #ACR24 Abstr#2651 https://t.co/AV3RcuSKpV https://t.co/xrax025TzP
      How often do you ask about #fatigue, #depression & #anxiety in pts with RMDs?

      Study of >1000 pts found anxiety s

      Mrinalini Dey DrMiniDey

      1 month ago
      How often do you ask about #fatigue, #depression & #anxiety in pts with RMDs? Study of >1000 pts found anxiety symptoms in 1/3 pts and significant association between fatigue & anxiety and depression Highlights importance of regular review of MH symptoms Ab2657 #ACR24 @RheumNow https://t.co/0zMOMybrCI
      A#2652
      NEWTON study 🇫🇷 Retrosp cohort

      51% relapse. Median @8.7 mos, dose 9mg pred
      Rf: limb art involv- HR 1.9
      Pre

      Eric Dein ericdeinmd

      1 month ago
      A#2652 NEWTON study 🇫🇷 Retrosp cohort 51% relapse. Median @8.7 mos, dose 9mg pred Rf: limb art involv- HR 1.9 Pred taper speed not risk for relapse Most relapse -> incr GCs Toci 1/3 at dx, 50% stopped -61% d/c due to remission, 39% SEs -1/3 relapse after d/c @RheumNow #ACR24 https://t.co/NP0wieDmvo
      Peyrac et al. 211 GCA. Relapse in 52% at median 261 days (so 1st year). 83% on GCs at relapse, median dose 6.5mg pred. 3

      Richard Conway RichardPAConway

      1 month ago
      Peyrac et al. 211 GCA. Relapse in 52% at median 261 days (so 1st year). 83% on GCs at relapse, median dose 6.5mg pred. 36% relapse post-toc discontinuation, at median 133 days. 64% no relapse when toc stopped, at median 511 days @RheumNow #ACR24 Abstr#2652 https://t.co/NqtdDNGGoc https://t.co/mXD8x7O6Ww
      What is the effect of cs/bDMARDs on weight in #PsA?

      ⬇️Weight loss seen with:
      IL17i
      IL23i
      csDMARDs

      ⬆️Weight gai

      Mrinalini Dey DrMiniDey

      1 month ago
      What is the effect of cs/bDMARDs on weight in #PsA? ⬇️Weight loss seen with: IL17i IL23i csDMARDs ⬆️Weight gain seen with: TNFi IL12/23i Important to consider #comorbidity & #BMI in management decisions in PsA Ab2639 #ACR24 @RheumNow
      Do TNFis and JAKis Prevent Cancer!?
      1 month ago
      A New ACR

      Dr. Jack Cush highlights a few notable changes to the ACR meeting format this year, and offers pointers on th

      Dr. John Cush RheumNow

      1 month ago
      A New ACR Dr. Jack Cush highlights a few notable changes to the ACR meeting format this year, and offers pointers on the best way to stay informed and abreast of reporting from the #ACR24 Convergence meeting in Washington, DC. https://t.co/YmI6s1TanV https://t.co/hsByGEBtnz
      A#2648
      PET for GCA
      Delayed imaging at 180 min improve dx performance for pts on GCs
      Optimal PET w/in 3 days of GC, most

      Eric Dein ericdeinmd

      1 month ago
      A#2648 PET for GCA Delayed imaging at 180 min improve dx performance for pts on GCs Optimal PET w/in 3 days of GC, most patients unable to do w/in that window Delay has sensitivity 92% even on prednisone - may be good tool for pts unable to get early PET/CT #ACR24 @RheumNow https://t.co/kxpNfRqkGN
      Study by Maria Dall'Era et al. compared voclosporin-based triple immunosuppressive therapy with high-dose GC in active l

      Antoni Chan MD (Prof) synovialjoints

      1 month ago
      Study by Maria Dall'Era et al. compared voclosporin-based triple immunosuppressive therapy with high-dose GC in active lupus nephritis. - Fewer adverse events in the voclosporin group, despite a higher incidence of specific issues like decreased GFR and hypertension. - 25%… https://t.co/ToRu2rdErC https://t.co/uUXzNNuLDb
      @YooJinKimYJK @andreafava et al: 20% of pts in their #lupus cohort had recurrent pericarditis.
      Majority had 1 recurrenc

      sheila RHEUMarampa

      1 month ago
      @YooJinKimYJK @andreafava et al: 20% of pts in their #lupus cohort had recurrent pericarditis. Majority had 1 recurrence (51%) Independent predictors of recurrence: Younger age Prednisone tx Active dse Time from initial episode 🔅regular ffup is 🔑 @RheumNow #ACR24 abs2372 https://t.co/UELwE31X0u

      Podcasts

      • Bah Humbug Vitamin D (12.20.2024)
      • 54K Peptic Ulcers Annually (12.13.2024)
      • Don’t Buy Guitars (12.6.2024)

      Catch up on Conference Podcasts

      Key Conference Topics

      Additional Topics

      Filter by Type

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright 2024 All Rights Reserved.

      ×